Life360, Inc.·4

Mar 23, 6:19 PM ET

Hulls Chris 4

4 · Life360, Inc. · Filed Mar 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Life360 (LIF) Director Chris Hulls Sells Shares, Exercises Options

What Happened

  • Chris Hulls, a director of Life360, exercised options/converted a derivative to acquire 27,000 shares at $8.19 per share (cost $221,130) on March 19, 2026. On the same date, Hulls sold 15,133 shares in an open‑market transaction for a weighted average price of $39.43, netting approximately $596,694.
  • The filing also shows a matching derivative disposition of 27,000 shares at $0.00, which in practice typically reflects shares surrendered/withheld in connection with the exercise (e.g., to cover taxes or exercise costs).

Key Details

  • Transaction date: March 19, 2026.
  • Exercise/acquired: 27,000 shares at $8.19 (total $221,130).
  • Surrender/derivative disposed: 27,000 shares at $0.00 (reported as a derivative disposition).
  • Sale: 15,133 shares sold at a weighted average $39.43, total proceeds about $596,694. (Sale prices ranged $39.23–$39.71 per share; weighted average reported.)
  • Sale conducted under a pre-established Rule 10b5‑1 trading plan adopted Dec 16, 2025 (per footnote); the plan was adopted when the reporting person said they were not aware of material nonpublic information.
  • Shares owned after the transactions are not specified in the excerpt provided; consult the full Form 4 for aggregate holdings and any additional footnotes.

Context

  • This is a mixed transaction: an option exercise (acquisition) combined with an open‑market sale. Sales under a Rule 10b5‑1 plan are typically automatic and pre‑planned rather than ad hoc decisions about company prospects.
  • The reported $0.00 derivative disposition likely reflects shares withheld or surrendered to cover exercise costs or taxes (common in net/withholding option exercises), not a cash sale.
  • The Form 4 was filed on March 23, 2026 for transactions dated March 19, 2026; that filing timing is consistent with the usual Form 4 requirement (filed within two business days).

Insider Transaction Report

Form 4
Period: 2026-03-19
Hulls Chris
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2][F3]
    2026-03-19$8.19/sh+27,000$221,130349,452 total
  • Sale

    Common Stock

    [F1][F4][F2][F3]
    2026-03-19$39.43/sh15,133$596,694334,319 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F6]
    2026-03-1927,000206,801 total
    Exercise: $8.19Exp: 2028-05-20Common stock (27,000 underlying)
Holdings
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
Footnotes (6)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  • [F2]Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  • [F3]Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F4]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  • [F5]Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  • [F6]The stock option is fully vested and exercisable.
Signature
/s/ Jay Sood, Attorney-in-Fact|2026-03-23

Documents

1 file
  • 4
    wk-form4_1774304360.xmlPrimary

    FORM 4